Nyhetsarkiv for Forskningsgruppe for hjernekreft immunologi og terapi
BORTEM-17 interim analysis results and small molecule inhibitor targeting CSPG4/NG2 in glioblastoma at American Association for Cancer Research (AACR 2024) April 5-10, 2024
BORTEM-17 interim analysis results and small molecule inhibitor targeting CSPG4/NG2 in glioblastoma at American Association for Cancer Research (AACR 2024) April 5-10, 2024
It was a great privilege to participate at ‘AACR Annual Meeting 2024’, a large and important conference for cancer research, the place where scientists, clinicians, survivors, and patients, gather to share and discuss the latest breakthroughs.
- august 2024 (1)
- juni 2024 (3)
- september 2023 (2)
- mai 2023 (1)
- september 2021 (1)
- mai 2021 (1)
- mars 2021 (1)
- februar 2021 (1)
- oktober 2020 (1)
- august 2019 (1)
- november 2018 (1)
- oktober 2018 (1)
- mai 2018 (1)
- november 2017 (1)
- juni 2014 (1)